Study: Tocotrienols Lower Cholesterol Levels

Carotech Inc. (Edison, NJ) has announced the results of a new study linking its tocopherol-tocotrienol complex to significant reductions in total and bad cholesterol levels.

In a double-blind, placebo-controlled study, 32 subjects with high cholesterol levels supplemented with 300 mg of Tocomin Suprabio or placebo daily for six months. Fasting blood and vitamin E (tocotrienol and alpha-tocopherol) levels were checked at baseline and every four weeks.

By the fourth month of the study, the tocomin group had experienced significant reductions in both total and low-density lipoprotein (LDL) cholesterol. These reductions continued into the fifth and sixth months of supplementation, with LDL levels reduced by 12.8% and 17.3% respectively, compared to baseline.

The placebo group showed only “negligible changes” in cholesterol levels throughout the study.

Triglyceride and high-density lipoprotein (HDL) cholesterol levels saw no significant fluctuations in either group during the study.

Carotech Inc. vice president WH Leong attributed the study results to SubraBio’s unique self-emulsifying system.

“Since an increase in tocotrienols’ blood level brings about significant cholesterol reduction, it is therefore important to ensure consistent and increased absorption of tocotrienol,” said Leong. “The SupraBio self-emulsifying system is unique and guarantees an average of 250% increase in tocotrienol absorption and hence improves tocotrienol bioavailability for the various positive health effects reported including cholesterol reduction.”